The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical ...

SIGA Technologies (NASDAQ:SIGA) announced Thursday that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approved ...

Trading Advice for Siga Technologies Inc. SIGA including day trading swing trading and long term investing plans for SIGA ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

John Boadu, Director General (DG) of the State Interests and Governance Authority (SIGA), has called on the incoming ...

It’s déjà vu for Siga Technologies and its smallpox antiviral Tpoxx. At an interim analysis of a second mpox trial, the drug again missed the mark on a key measure of disease resolution.

(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox, mpox, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox ...